![Hugh Davis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hugh Davis
President at
ACLARIS THERAPEUTICS, INC.
Net worth: 206 684 $ as of 30/05/2026
Profile
Dr. Hugh M.
Davis is a President, Chief Operating Officer & Director at Aclaris Therapeutics, Inc. He is on the Board of Directors at Aclaris Therapeutics, Inc. Dr. Davis was previously employed as a President, Chief Business & Development Officer by Biosion, Inc., a Chief Business Officer by Frontage Holdings Corp., and a Vice President-Clinical Pharmacology by Janssen Research & Development LLC.
He received his undergraduate degree from Gannon University and a doctorate degree from Villanova University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 13/04/2026 | 45,425 ( 0.03% ) | 206 684 $ | 30/05/2026 |
Hugh Davis active positions
| Companies | Position | Start |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | President | 17/11/2024 |
Former positions of Hugh Davis
| Companies | Position | End |
|---|---|---|
| FRONTAGE HOLDINGS CORPORATION | Corporate Officer/Principal | 29/02/2020 |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Corporate Officer/Principal | 31/12/2017 |
Biosion, Inc.
 Biosion, Inc. BiotechnologyHealth Technology Engages in research and development of antibody drugs | President | - |
Training of Hugh Davis
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
91
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Aclaris Therapeutics, Inc.
 Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
Gannon University
 Gannon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Commercial Services |
Frontage Holdings Corp.
 Frontage Holdings Corp. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Biosion, Inc.
Biosion, Inc. BiotechnologyHealth Technology Engages in research and development of antibody drugs | Health Technology |
- Stock Market
- Insiders
- Hugh Davis
